Interferon beta 1a (Rebif®) in relapsing remitting multiple sclerosis-Reference-Cited by-同舟云学术

Interferon beta 1a (Rebif®) in relapsing remitting multiple sclerosis

Published:2021-02-15 Issue:5 Volume:82 Page:707-715
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev Res

Author:

Sánchez Reinier Cardentey¹,Fe Amado Díaz¹,Suarez Alejandro Peláez¹,Grass Dayme¹,Vega Teresa Morgado¹,Canal Armando Sánchez²,Siniscalco Dario³^ORCID,Angeles Robinson Agramonte María⁴

Affiliation:

1. Neuromuscular Diseases Clinic International Center for Neurological Restoration Habana Cuba

2. Division of Neuromuscular Diseases Clinic Abel Santamaria Cuadrado University Hospital Pinar del Río Cuba

3. Department of Experimental Medicine Division of Biotechnology, Molecular Biology and Histology, University of Campania L. Vanvitelli Naples Italy

4. Neuroimmunology Department, Research Center International Center for Neurological Restoration Habana Cuba

Publisher

Wiley

Subject

Drug Discovery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ddr.21798

Reference51 articles.

1. Alcoriza Rodríguez S. (2015).Esclerosis múltiple.http://147.96.70.122/Web/TFG/TFG/Memoria/CLAUDIA%20MORAIS%20VARGAS.pdf

2. Association between multiple sclerosis and epilepsy: large population-based record-linkage studies

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decades-delayed onset of subcutaneous granulomata and calcifications from interferon-beta-1a in a patient with multiple sclerosis;Neuroimmunology Reports;2023-12

2. Personalized treatments in neuropsychiatric disorders;Drug Development Research;2021-07